Procalcitonin as diagnostic biomarker of sepsis
Authors:
- Stephan HarbarthSHStephan Harbarth
- 1 May 2013
- journal article
- editorial
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 13 (5) , 382-384
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2013
- Year in review 2011: Critical Care - infectionCritical Care, 2012
- New Approaches to Sepsis: Molecular Diagnostics and BiomarkersClinical Microbiology Reviews, 2012
- An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patientsIntensive Care Medicine, 2012
- Procalcitonin to Guide Duration of Antimicrobial Therapy in Intensive Care Units: A Systematic ReviewClinical Infectious Diseases, 2011
- When once is not enough – further evidence of procalcitonin-guided antibiotic stewardshipCritical Care, 2009
- Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysisThe Lancet Infectious Diseases, 2007
- Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysisCritical Care Medicine, 2006
- Quantifying Uncertainty: Physicians' Estimates of Infection in Critically Ill Neonates and ChildrenClinical Infectious Diseases, 2004
- Procalcitonin and the Calcitonin Gene Family of Peptides in Inflammation, Infection, and Sepsis: A Journey from Calcitonin Back to Its PrecursorsThe Journal of Clinical Endocrinology & Metabolism, 2004